Gloria Yaluff

Asuncion, ASU 2169, Paraguay

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

In vitro and in vivo studies of dehydroxylated-isoquines and -isotebuquines against trypanosomatids: a preclinical drug candidate for treatment of cutaneous leishmaniasis.

In vitro and in vivo studies of dehydroxylated-isoquines and -isotebuquines against trypanosomatids: a preclinical drug candidate for treatment of cutaneous leishmaniasis.

Journal: RSC medicinal chemistry

Published: January 05, 2026

A Novel Triose Phosphate Isomerase Inhibitor With Dual Trypanosomicidal Activity was Identified Using Artificial Intelligence-Based Virtual Screening.

A Novel Triose Phosphate Isomerase Inhibitor With Dual Trypanosomicidal Activity was Identified Using Artificial Intelligence-Based Virtual Screening.

Journal: ChemMedChem

Published: October 10, 2025

Exploring the Anti-Chagas Activity of Zanthoxylum chiloperone's Seedlings Through Metabolomics and Protein-Ligand Docking.

Exploring the Anti-Chagas Activity of Zanthoxylum chiloperone's Seedlings Through Metabolomics and Protein-Ligand Docking.

Journal: Plants (Basel, Switzerland)

Published: February 05, 2025

The quinoline framework and related scaffolds in natural products with anti-Leishmania properties.

The quinoline framework and related scaffolds in natural products with anti-Leishmania properties.

Journal: Frontiers in chemistry

Published: February 04, 2025

Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas Disease.

Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas Disease.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 24, 2022

Preclinical Studies in Anti-Trypanosomatidae Drug Development.

Preclinical Studies in Anti-Trypanosomatidae Drug Development.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 02, 2021

In vitro susceptibility to benznidazole, nifurtimox and posaconazole of Trypanosoma cruzi isolates from Paraguay

In vitro susceptibility to benznidazole, nifurtimox and posaconazole of Trypanosoma cruzi isolates from Paraguay

Journal: Biomedica : revista del Instituto Nacional de Salud

Published: August 28, 2019

A Nature-Inspired Design Yields a New Class of Steroids Against Trypanosomatids.

A Nature-Inspired Design Yields a New Class of Steroids Against Trypanosomatids.

Journal: Molecules (Basel, Switzerland)

Published: August 17, 2019

Helietta apiculata: a tropical weapon against Chagas disease.

Helietta apiculata: a tropical weapon against Chagas disease.

Journal: Natural product research

Published: May 11, 2018

Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment.

Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment.

Journal: Memorias do Instituto Oswaldo Cruz

Published: July 07, 2017

In vitro antiprotozoal activity of (S)-cis-Verbenol against Leishmania spp. and Trypanosoma cruzi.

In vitro antiprotozoal activity of (S)-cis-Verbenol against Leishmania spp. and Trypanosoma cruzi.

Journal: Acta tropica

Published: October 12, 2016

New approach towards the synthesis of selenosemicarbazones, useful compounds for Chagas' disease.

New approach towards the synthesis of selenosemicarbazones, useful compounds for Chagas' disease.

Journal: European journal of medicinal chemistry

Published: September 11, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026